Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
5,130.00
-100.00 (-1.91%)
Oct 23, 2026, 3:30 PM KST
| Market Cap | 122.64B -13.5% |
| Revenue (ttm) | 279.55B +14.8% |
| Net Income | 5.05B +1,117.6% |
| EPS | 211.21 +1,123.6% |
| Shares Out | 23.91M |
| PE Ratio | 24.29 |
| Forward PE | n/a |
| Dividend | 50.00 (0.97%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 33,106 |
| Open | 5,220.00 |
| Previous Close | 5,230.00 |
| Day's Range | 5,060.00 - 5,220.00 |
| 52-Week Range | 4,700.00 - 9,300.00 |
| Beta | 0.31 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |